XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Tax Matters (Tables)
6 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets and liabilities

Significant components of the Company’s deferred tax assets and liabilities as of June 30, 2022, and December 31, 2021 were as follows:

(in thousands)

    

June 30, 2022

    

December 31, 2021

Deferred tax assets:

 

  

 

  

Loss carryforwards

$

2,464

$

2,244

Capitalized costs

 

103

 

127

Stock option granted

1,142

1,060

Policy acquisition costs

4,813

3,640

General business credits

6

6

Derivative option allowance

510

Sec 163(j) limitation

172

171

Benefit reserves

 

9,889

 

6,720

Property and equipment

59

33

Unrealized losses on investments

5,654

Other

1,464

1,464

Total deferred tax assets

 

25,766

 

15,975

Less valuation allowance

 

(22,108)

 

(14,431)

Total deferred tax assets, net of valuation allowance

 

3,658

 

1,544

Deferred tax liabilities:

 

  

 

  

Unrealized losses on investments

 

 

1,084

Intangible assets

 

147

 

147

Derivative option allowance

 

2,906

 

Bond Discount

605

313

Total deferred tax liabilities

 

3,658

 

1,544

Net deferred tax assets

$

$

Schedule of effective tax rate reconciliation

There was income tax benefit of $2.1 million and expense of $0.7 million for the three months ended June 30, 2022, and 2021, respectively. There was income tax expense of $2.6 million and $2.2 million for the six months ended June 30, 2022 and 2021, respectively. This differed from the amounts computed by applying the statutory U.S. federal income tax rate of 21% to pretax income, as a result of the following:

Three months ended June 30, 

Six months ended June 30, 

(in thousands)

    

2022

    

2021

    

2022

    

2021

Computed expected income tax benefit (expense)

$

(409)

$

892

$

(1,508)

$

927

Reduction (increase) in income taxes resulting from:

 

 

  

 

 

  

IMR and reinsurance

61

(108)

(18)

(175)

Nondeductible expenses

(3)

(2)

(5)

(3)

Change in valuation allowance

 

2,480

 

(1,532)

 

(1,052)

(2,933)

Dividends received deduction

3

5

Deferred tax adjustment

(4)

(14)

Subtotal of increases

 

2,534

 

(1,639)

 

(1,089)

 

(3,106)

Tax benefit (expense)

$

2,125

$

(747)

$

(2,597)

$

(2,179)